PRF Technologies

PRF Technologies Interest Expense

The Interest Expense of PRF Technologies (PRFX) as of Nov 2, 2026 is 107,000.00 USD. In the previous year, Interest Expense was 408,000.00 USD — a change of -73.77% (lower).

Interest Expense

107,000.00USD

YoY

-73.77%

Last updated:

Interest Expense of PRF Technologies is 2024 107,000.00 USD. Interest Expense of PRF Technologies was 2023 408,000.00 USD. It decreases by -73.77% lower compared to the previous year.

The PRF Technologies Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-240,000.00 USD
Jan 1, 2018
-330,000.00 USD
Jan 1, 2019
-540,000.00 USD
Jan 1, 2020
-990,000.00 USD
Jan 1, 2021
-20,000.00 USD
Jan 1, 2022
100,000.00 USD
Jan 1, 2023
408,000.00 USD
Jan 1, 2024
107,000.00 USD
The PRF Technologies Interest Expense history
YEARInterest ExpenseYoY
107,000.00USD-73.77%
408,000.00USD+308.00%
100,000.00USD-600.00%
-20,000.00USD-97.98%
-990,000.00USD+83.33%
-540,000.00USD+63.64%
-330,000.00USD+37.50%
-240,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PRF Technologies Stock analysis

What does PRF Technologies do? PainReform Ltd. develops reformulated pain therapeutics to extend efficacy, minimize adverse effects, and improve patient convenience. The company focuses on enhancing established pharmaceuticals through its proprietary technology, targeting faster recovery of motor function. Its products are designed for healthcare providers and patients seeking advanced pain management solutions. The business model centers on licensing its reformulation technology to pharmaceutical partners. These partners integrate PainReform's solutions into their existing drug portfolios, leveraging the technology to improve product performance without developing new compounds from scratch. The primary buyers are established pharmaceutical companies looking to extend patent life and enhance market competitiveness of their pain management drugs. PainReform's technology addresses key pain management challenges by prolonging drug effects and reducing side effects. This positions the company as a strategic partner for pharmaceutical firms aiming to optimize their therapeutic offerings. The target segments include chronic pain patients and healthcare systems seeking more effective and safer pain treatment options. PRF Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PRF Technologies stock

Interest Expense of PRF Technologies is 107,000.00 USD in 2024.

Interest Expense of PRF Technologies changed from 408,000.00 USD to 107,000.00 USD, representing a -73.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense PRF Technologies since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's PRF Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — PRF Technologies

All Key Metrics — PRF Technologies